FDA Inspection
Reckitt Benckiser, LLCReckitt Benckiser, LLC – FDA Inspection, Aug 17, 2017
Record Details
This FDA Inspection record concerns Reckitt Benckiser, LLC, with an inspection on August 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8a45f5e7-9282-42f2-aad5-5db2d528bba0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022265
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reckitt Benckiser, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 12, 2016 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 10, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Reckitt Benckiser, LLC
- FDA Inspection 971963 - 2016-05-12
- FDA Inspection 781026 - 2012-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.